HBM Healthcare Investments - Share price HBM Healthcare Investments registered share

en de

Contact

News

HBM Healthcare Investments achieves net profit of CHF 67 million for the year and proposes a par-value repayment of CHF 1.50 per share to shareholders' meeting

Successful IPO for Enanta Pharmaceuticals

Vivacta sold to major pharmaceutical company for USD 90 million

more

Finanzberichte

Financial Reports

Quarterly Report December 2012

more

Company Presentation

more

Share Price

Aktienkurs

SIX Swiss Exchange Ticker
HBMN

Key Figures

as at 15 May 2013	CHF
NAV per share	75.32
Net assets	659 Mio.

© HBM Healthcare Investments AG